Benzinga | Nov 10, 2021 04:08PM EST

ADMA Biologics Q3 EPS $(0.13) Beats $(0.14) Estimate, Sales $20.70M Beat $18.72M Estimate

ADMA Biologics (NASDAQ:ADMA) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 31.58 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $20.70 million which beat the analyst consensus estimate of $18.72 million by 10.58 percent. This is a 101.44 percent increase over sales of $10.28 million the same period last year.